Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM family” cooperative group
Anna Berg(Stichting Kinderoncologie Nederland), Elisabeth R. van Wering(Stichting Kinderoncologie Nederland), Ursula Köller(Klinik Hietzing), Oskar A. Haas(St Anna Children's Hospital), Andrea Biondi(University of Milano-Bicocca), Giuseppe Basso(University of Padua), Klaus‐Michael Debatin(German Centre for Cardiovascular Research), Charlotte M. Niemeyer(University of Freiburg), Willem A. Kamps(Pediatric Oncology Group), Jochen Harbott(Justus-Liebig-Universität Gießen), Fritz Lampert, Wolf‐Dieter Ludwig(Helios Hospital Berlin-Buch), Claus R. Bartram(Goethe University Frankfurt), Yves Benoît(Ghent University Hospital)
Cited by 109
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k